secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K/A
Filed at:   2022-12-15T23:59:59+00:00
Accession:  0001558370-22-018727
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azenta files amended 8-K with audited financials for acquired B Medical Systems; 2021 net turnover EUR 111.8M
--------------------------------------------------------------------------------

- Acquisition of B Medical Systems closed Oct 3, 2022; amendment provides required financial statements.
- Audited 2021 net turnover EUR 111.8M, up from EUR 61.9M in 2020; net profit EUR 10.2M vs EUR 0.1M.
- Total assets at Dec 31, 2021: EUR 136.0M vs EUR 89.9M a year earlier.
- Unaudited pro forma combined financials for year ended Sep 30, 2022 filed as Exhibit 99.3.
- B Medical Systems Holding S.A. voluntarily liquidated on Oct 4, 2022; financials prepared on going concern basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000155837022018727/0001558370-22-018727-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000155837022018727/azta-20221003x8ka.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-018727

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer